iCrowd Newswire – Jul 6, 2020
Avian influenza or bird flu is a virus which affects wild and domestic birds such as geese, duck, chicken, and turkeys. Some strains of the virus have a potential of creating a pandemic similar to the COVID-19 virus and can be transmitted to humans. The global avian influenza vaccine market report by Market Research Future (MRFR) stresses on the developments in vaccines, clinical trials, and its potential for the period of 2019 to 2025 (forecast period). It also touches on the impact of the COVID-19 virus on the market.
Download Sample Report For Free: To Know the Impact of COVID-19 on this Industry https://www.marketresearchfuture.com/sample_request/8769
Avian Influenza Vaccine Market Scope
The global avian influenza vaccine market size is predicted to reach USD 735.22 million by 2025. It can garner revenues at 7.25% CAGR over the forecast period. Large cases of avian diseases are one of the biggest drivers of the market. The sudden outbreak of avian flu in 2008 has culminated in culling of birds on a large scale. In order to avoid a repeat of the incident, vaccine manufacturers are investing in research and development to create possible vaccines for various strains of the H5N1 virus. This is exemplified by the license conferred to Sanofi Pasteur by the U.S. FDA for the H5N1 vaccine.
Rising investments in poultry farms due to the increasing gravitation towards protein by consumers can boost the global avian influenza vaccine market demand. Researchers at Kansas University had collaborated with Icahn School of Medicine for development of a vaccine against strains of bird flu. Development of live vaccines for enhancing the immunity of birds against germs and bacteria can bode well for the market.
Avian Influenza Vaccine Market Segmentation
The global avian influenza vaccine market has been segmented by strain and application.
The market, based on strain, has been segmented into H5, H7, and H9.
Based on application, the avian influenza vaccine market has been segmented into goose & duck, chicken, and turkey.
Avian Influenza Vaccine Market Regional Analysis
The global avian influenza vaccine market, based on region, has been divided into the APAC & Middle East, Europe, Americas, and Africa.
The APAC & Middle East is likely to dominate the global avian influenza vaccine market. This can be attributed to the increasing production of poultry and the subsequent rise in avian influenza outbreaks in the region. According to a recent report from the Foreign Agricultural Service/USDA, China had registered 13,800 thousand metric tons of chicken meat production in 2019. Furthermore, various government initiatives for rapid and effective response for zoonotic diseases can augur favorably for the market.
Europe is estimated to be the second-largest region during the review period. The growing dependence on poultry for protein and presence of various biotechnology firms for production of vaccines can influence the regional market growth. According to the European Commission, the European Union (EU) produced 15.2 million tons of poultry meat in 2018. Rise of veterinary clinics and production of meat can both evoke massive demand in the global avian influenza vaccine market.
The Americas is estimated to demonstrate significant market growth owing large number of veterinarian clinics, investment in healthcare, and focus on animal health. According to the North American Meat Institute, the US exported 3.7 million metric tons (MT) of poultry and poultry variety meats in 2017. This is expected to accelerate the demand for avian influenza vaccines among the populace. Recently, a cell-based vaccine, Audenz, by Seqirus has been approved by the U.S. FDA for use among children 6 and older.
Avian Influenza Vaccine Market Competition Outlook
JOVAC, Avimex Animal Health, Guangdong Wenshi Dahuanong Biotechnology Co., Ltd, Medion, Zoetis, Tianjin Ringpu Bio-Technology Co., Ltd, QYH BIOTECH COMPANY LIMITED, Boehringer Ingelheim International GmbH, CAVAC, PT Japfa Comfeed Indonesia Tbk, Chengdu Tech-bank Biological Products Co., Ltd, Merck Animal Health, Ceva, FATRO S.P.A., and Yebio Bioengineering Co., Ltd, are key players of the global avian influenza vaccine market.
Strategic agreements are witnessed in the global market as public and private agencies are investing in the animal husbandry sector. Corporations are collaborating in creating educational programs for veterinarians and promoting animal health.
OBTAIN RESEARCH REPORT DETAILS WITH TOC, Considering Covid19 Impact @
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312
Email: [email protected]
Keywords: Covid19 Impact Analysis, Avian Influenza Vaccine Market, Avian Influenza Vaccine Market size, Avian Influenza Vaccine Market share, Avian Influenza Vaccine Market 2020, Avian Influenza Vaccine Market growth, Global Avian Influenza Vaccine Market, Avian Influenza Vaccine Industry